{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:56:30Z","timestamp":1792446990658,"version":"4.5.0"},"reference-count":59,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Expectations"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Psychotropic medications are a common treatment modality for people living with severe and persistent mental illness (SPMI). While effective in reducing relapse and hospitalisation, psychotropic medications cause numerous side effects, varying in nature and severity. Identification and management of side effects is crucial in the ongoing management of SPMI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To characterise the side effects of psychotropic medications, experienced by a sample of consumers living with SPMI, using a validated tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting and Participants<\/jats:title><jats:p>Consumers with SPMI living in the community were recruited from all 25 community pharmacies across four Australian regions, which were allocated to the intervention arm of the Bridging the Gap between Physical and Mental Illness (<jats:italic>PharMIbridge<\/jats:italic>) randomised controlled trial (RCT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>Responses to the <jats:italic>My Medicines &amp; Me Questionnaire<\/jats:italic> (<jats:italic>M3Q)<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Consumers (<jats:italic>n<\/jats:italic>\u2009=\u2009156) most frequently reported side effects in the categories of sleep\u2010related side effects (80.8%, <jats:italic>n<\/jats:italic>\u2009=\u2009126), mood\u2010related side effects (75.6%, <jats:italic>n<\/jats:italic>\u2009=\u2009118) and weight and appetite changes (60.3%, <jats:italic>n<\/jats:italic>\u2009=\u2009107). Daytime somnolence was the most reported individual side effect (68.6%, <jats:italic>n<\/jats:italic>\u2009=\u2009107). Mood\u2010related side effects were ranked as the most bothersome, followed by sleep\u2010related side effects and weight and appetite changes. More than one\u2010quarter (29.5%, <jats:italic>n<\/jats:italic>\u2009=\u200946) of consumers reported choosing not to take their medications due to side effects. Consumers more frequently told family and friends about the side effects rather than healthcare professionals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>An overwhelming majority of consumers experienced at least one side effect attributed to their psychotropic medication, with many experiencing multiple. These findings highlight the critical need to regularly engage with consumers to discuss, identify and manage side effects to treatment burden, reduce risk of non\u2010adherence and improve their treatment experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient or Public Contribution<\/jats:title><jats:p>The <jats:italic>PharMIbridge<\/jats:italic> RCT included a training programme and intervention service that was co\u2010designed and co\u2010delivered with people with lived experience of mental illness. The research team, expert advisory panel and mentors who supported the delivery and implementation of the training and intervention included participants who have lived experience of mental illness or caring for someone with mental illness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ANZCTR12620000577910.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hex.70122","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:30:47Z","timestamp":1733941847000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-5394","authenticated-orcid":false,"given":"Jack C.","family":"Collins","sequence":"first","affiliation":[{"name":"The University of Sydney School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-674X","authenticated-orcid":false,"given":"Amanda J.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland Griffith University Nathan Australia"},{"name":"School of Pharmacy and Medical Sciences Griffith University Gold Coast Australia"},{"name":"School of Pharmacy, Faculty of Health and Behavioural Sciences University of Auckland Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-4467","authenticated-orcid":false,"given":"Sara S.","family":"McMillan","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland Griffith University Nathan Australia"},{"name":"School of Pharmacy and Medical Sciences Griffith University Gold Coast Australia"},{"name":"Centre for Mental Health Griffith University Nathan Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-6525","authenticated-orcid":false,"given":"Jie","family":"Hu","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland Griffith University Nathan Australia"},{"name":"School of Pharmacy and Medical Sciences Griffith University Gold Coast Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-3351","authenticated-orcid":false,"given":"Sarira","family":"El\u2010Den","sequence":"additional","affiliation":[{"name":"The University of Sydney School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4569-1226","authenticated-orcid":false,"given":"Helena","family":"Roennfeldt","sequence":"additional","affiliation":[{"name":"Menzies Health Institute Queensland Griffith University Nathan Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-8150","authenticated-orcid":false,"given":"Claire L.","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"The University of Sydney School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00648"},{"key":"e_1_2_12_3_1","unstructured":"\u201cMental Health Inquiry Report no. 95 \u201d Productivity Commission 2020 https:\/\/www.pc.gov.au\/inquiries\/completed\/mental-health\/report\/mental-health.pdf."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.177901"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420979353"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00158-4"},{"issue":"7","key":"e_1_2_12_7_1","article-title":"Intermittent Drug Techniques for Schizophrenia","author":"Sampson S.","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20699"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2016.04.005"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20100708-01"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000017"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200009000-00006"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0317"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-12-20"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2022.619"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030238"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2539"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-021-00374-y"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114562090"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04324-0"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02661-6"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003262"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0284-9"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32819f8f17"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm038"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/09638237.2016.1222060"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.05.060"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415608244"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.12349"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000280"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1039856216634825"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2013.11196"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-009-9287-y"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/ejihpe13080110"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039983"},{"key":"e_1_2_12_36_1","unstructured":"\u201cIdentifier ACTRN12620000577910. A Cluster Randomised Controlled Trial of a PharMacist\u2010Led Intervention for People Living With Severe and Persistent Mental Illness to Support Medication Adherence Physical Health and Psychological Wellbeing \u201d Australian and New Zealand Clinical Trials Registry 2022 https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=377483."},{"key":"e_1_2_12_37_1","unstructured":"\u201cBlended Mental Health First Aid in the Pharmacy \u201d Mental Health First Aid Australia 2021 https:\/\/www.mhfa.com.au\/our-courses\/adults-supporting-adults\/standard-mental-health-first-aid-for-pharmacy\/."},{"key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"964\u2013981","DOI":"10.1177\/00178969221130461","article-title":"A Training Programme for Community Pharmacists to Support People Living With Severe and Persistent Mental Illness: Intervention Mapping in the Context of a Pandemic","volume":"81","author":"McMillan S. S.","year":"2022","journal-title":"Health Education Journal"},{"key":"e_1_2_12_39_1","first-page":"807\u2013816.e2","article-title":"Evaluation of a Training Program to Support the Implementation of a Community Pharmacist\u2010led Support Service for People Living with Severe and Persistent Mental Illness","volume":"63","author":"Ng R.","year":"2023","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-023-02443-x"},{"key":"e_1_2_12_41_1","doi-asserted-by":"crossref","unstructured":"D.Ashoorian \u201cMy Medicines & Me Questionnaire (M3Q): A Side Effect Questionnaire for Mental Health Medications \u201d2014 https:\/\/www.chiefpsychiatrist.wa.gov.au\/wp-content\/uploads\/2016\/10\/M3Q_Fillable.pdf.","DOI":"10.1016\/j.sapharm.2014.07.091"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.10.022"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000072"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125315598466"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe7113"},{"key":"e_1_2_12_46_1","unstructured":"\u201dModified Monash Model \u201d Australian Government Department of Health and Aged Care 2021 https:\/\/www.health.gov.au\/health-topics\/rural-health-workforce\/classifications\/mmm."},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0952-0"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.06.031"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.2247"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211048410"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416641195"},{"key":"e_1_2_12_52_1","unstructured":"\u201cPsychosis and Schizophrenia in Adults: Prevention And Management [CG178] \u201d National Institute for Clinical Excellence 2014 https:\/\/www.nice.org.uk\/guidance\/cg178."},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2016.04.009"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.573479"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.35680\/2372-0247.1658"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1071\/AH21162"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/00207640231160102"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.579985"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720001841"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/09515070.2020.1785846"}],"container-title":["Health Expectations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.70122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:18:00Z","timestamp":1741576680000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hex.70122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/hex.70122"],"URL":"https:\/\/doi.org\/10.1111\/hex.70122","archive":["Portico"],"relation":{},"ISSN":["1369-6513","1369-7625"],"issn-type":[{"value":"1369-6513","type":"print"},{"value":"1369-7625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70122"}}